Group 1 - The U.S. government announced a 39% tariff on Swiss imports, effective August 7, which is higher than the previous 31% tariff and more than double the tariff on EU imports, making Switzerland the hardest-hit European country by U.S. tariffs [2] - Switzerland's trade surplus with the U.S. exceeded $38 billion in 2024, prompting the U.S. to impose these high tariffs due to concerns over trade imbalances [2] - The Swiss government expressed dissatisfaction with the U.S. decision, highlighting that the trade surplus is not based on unfair practices and that they have unilaterally eliminated all industrial tariffs since January 1, 2024, allowing over 99% of U.S. goods to enter Switzerland duty-free [3] Group 2 - The imposition of the 39% tariff is expected to significantly impact the Swiss job market, with potential increases in short-term work and layoffs, particularly affecting key industries [3] - The pharmaceutical sector, which accounts for over half of Switzerland's exports to the U.S., is currently not covered by the new tariffs, but any future inclusion could lead to a GDP decline of at least 0.7% [3] - A high-level Swiss delegation, including the Federal President and the Minister of Economy, has been sent to Washington to negotiate and propose more attractive terms to reduce the tariff levels on Swiss exports [3] Group 3 - The situation illustrates the U.S. government's unilateral approach to trade, focusing primarily on trade surpluses without considering the broader economic context [4] - The case of Switzerland serves as a lesson for other countries on how to engage in trade with the U.S. and the challenges they may face [4]
瑞士成美关税打击最重欧洲国家
Sou Hu Cai Jing·2025-08-09 02:29